Linden Advisors LP Precigen, Inc. Transaction History

Linden Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $1.51 Million - $1.99 Million	-241,534 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.75 - $10.56 $567,637 - $1.6 Million	151,370 Added 167.88%	241,534 $2.46 Million
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $131,639 - $648,279	90,164 New	90,164 $306,000

144

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $164M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Linden Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Linden Advisors LP with notifications on news.